Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | The Vanguard Group | 1,450,425 5.460% | 1,450,425 (New Position) | Filing History |
| 2023-02-08 09:52 am Sale | 2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 2,257,846 8.500% | -960,111 (-29.84%) | Filing History |
| 2023-02-03 06:10 am Purchase | 2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Sumitomo Mitsui Trust Group, Inc. | 1,449,060 5.450% | 91,588 (+6.75%) | Filing History |
| 2023-02-01 10:11 am Purchase | 2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | FEDERATED HERMES INC. FHI | 4,239,554 16.000% | 544,625 (+14.74%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | BlackRock Inc. BLK | 1,884,885 7.100% | 125,295 (+7.12%) | Filing History |
| 2022-04-11 1:47 pm Purchase | 2022-03-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 3,217,957 12.200% | 1,161,883 (+56.51%) | Filing History |
| 2022-02-14 9:41 pm Purchase | 2021-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON | Arcturus Therapeutics Holdings Inc. ARCT | 28,125 12.380% | 28,125 (New Position) | Filing History |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | PRICE T ROWE ASSOCIATES INC /MD/ | 15,039 0.000% | -1,407,140 (-98.94%) | Filing History |
| 2022-02-14 1:07 pm Purchase | 2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | FEDERATED HERMES INC. FHI | 3,694,929 14.020% | 242,119 (+7.01%) | Filing History |
| 2022-02-14 06:04 am Purchase | 2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas, Inc. | 1,357,472 5.150% | 1,357,472 (New Position) | Filing History |
| 2022-02-11 09:40 am Purchase | 2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 2,056,074 7.800% | 2,056,074 (New Position) | Filing History |
| 2022-02-09 2:03 pm Sale | 2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 2,472,630 9.380% | -380,628 (-13.34%) | Filing History |
| 2022-02-04 06:05 am Purchase | 2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Sumitomo Mitsui Trust Group, Inc. | 1,357,472 5.140% | 1,357,472 (New Position) | Filing History |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | BlackRock Inc. BLK | 1,759,590 6.700% | -22,365 (-1.26%) | Filing History |
| 2021-11-09 12:03 pm Sale | 2021-10-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 2,853,258 10.840% | -1,105,761 (-27.93%) | Filing History |
| 2021-10-26 4:44 pm Sale | 2021-10-21 | 13D | Arcturus Therapeutics Holdings Inc. ARCT | Ultragenyx Pharmaceutical Inc. RARE | 1,200,000 4.600% | -200,000 (-14.29%) | Filing History |
| 2021-08-12 5:09 pm Sale | 2021-08-10 | 13D | Arcturus Therapeutics Holdings Inc. ARCT | Ultragenyx Pharmaceutical Inc. RARE | 1,400,000 5.300% | -800,000 (-36.36%) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 3,959,019 15.310% | 1,463,177 (+58.62%) | Filing History |
| 2021-02-16 3:09 pm Sale | 2020-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Cormorant Asset Management, LP | 0 0.000% | -1,144,537 (Position Closed) | Filing History |
| 2021-02-16 12:24 pm Purchase | 2020-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | PRICE T ROWE ASSOCIATES INC /MD/ | 1,422,179 5.400% | 1,422,179 (New Position) | Filing History |